Doyle Wealth Management Abb Vie Inc. Transaction History

Doyle Wealth Management

$1.16 Billion
Q3 2022

A detailed history of Doyle Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Doyle Wealth Management holds 34,715 shares of ABBV stock, worth $6.1 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

34,715

Previous 34,116 1.76%

Holding current value

$6.1 Million

Previous $5.23 Million 10.83%

% of portfolio

0.4%

Previous 0.42%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$134.21 - $153.93 $80,391 - $92,204	599 Added 1.76%	34,715 $4.66 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $154,409 - $196,305	-1,122 Reduced 3.18%	34,116 $5.23 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $170,650 - $211,728	1,293 Added 3.81%	35,238 $5.71 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $163,186 - $206,477	1,519 Added 4.68%	33,945 $4.6 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $263,978 - $299,655	2,481 Added 8.29%	32,426 $3.5 Million
Q2 2021 Aug 03, 2021	BUY	$105.21 - $117.21 $275,544 - $306,972	2,619 Added 9.58%	29,945 $3.37 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $162,247 - $178,615	1,586 Added 6.16%	27,326 $2.96 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $1.59 Million - $2.14 Million	19,713 Added 327.08%	25,740 $2.76 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $42,697 - $50,112	497 Added 8.99%	6,027 $528,000
Q2 2020 Aug 06, 2020	SELL	$73.37 - $98.18 $16,728 - $22,385	-228 Reduced 3.96%	5,530 $543,000
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $52,245 - $79,209	810 Added 16.37%	5,758 $439,000
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $7,790 - $9,747	108 Added 2.23%	4,948 $438,000
Q3 2019 Nov 05, 2019	BUY	$62.98 - $75.72 $102,342 - $123,045	1,625 Added 50.54%	4,840 $366,000
Q2 2019 Aug 15, 2019	BUY	$65.7 - $83.98 $394 - $503	6 Added 0.19%	3,215 $234,000
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $279,786 - $329,295	-3,627 Reduced 53.06%	3,209 $249,000
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $60,645 - $74,791	779 Added 12.86%	6,836 $630,000
Q3 2018 Nov 08, 2018	SELL	$88.91 - $98.84 $5.49 Million - $6.1 Million	-61,757 Reduced 91.07%	6,057 $573,000
Q2 2018 Aug 08, 2018	SELL	$89.78 - $106.23 $113,392 - $134,168	-1,263 Reduced 1.83%	67,814 $6.28 Million
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $30,455 - $40,782	-331 Reduced 0.48%	69,077 $6.54 Million
Q4 2017 Feb 07, 2018	SELL	$89.56 - $98.21 $187,269 - $205,357	-2,091 Reduced 2.92%	69,408 $6.71 Million
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $4.99 Million - $6.38 Million	71,499	71,499 $6.35 Million

Others Institutions Holding ABBV

# of Institutions

3,850

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $311B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Doyle Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Doyle Wealth Management with notifications on news.

Account

Doyle Wealth Management Abb Vie Inc. Transaction History